| (2R,6R)-hydroxynorketamine (0.25 to 2.0 mg/kg) + Placebo for depressive disorder, treatment-resistant | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| (2R,6R)-hydroxynorketamine (0.25 to 2.0 mg/kg) + Placebo for major depressive disorder | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Abbott Laboratories Infinity™ implantable deep brain stimulation system for depressive disorder, treatment-resistant | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Accelerated protocol of home Transcranial direct current stimulation for major depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Accelerated theta-burst stimulation treatment for depressive disorder, treatment-resistant | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Accelerated theta-burst stimulation treatment for major depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Activa Tremor Control Sys (DBS Implant) for depressive disorder, treatment-resistant | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Activa Tremor Control Sys (DBS Implant) for major depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Active - Conventional tDCS for major depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Active - HD tDCS for major depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 2 |
|---|
| active rTMS treatment for depressive disorder, treatment-resistant | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| active rTMS treatment for major depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Active tDCS for major depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| active tDCS + mindfulness meditation for major depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| active tDCS stimulating left DLPFC for depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Active transcranial direct current stimulation for depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Active Whole-Body Hyperthermia (Active WBH) for major depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Acupuncture for major depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 2 |
|---|
| acupuncture (strong reaction acupoints) + SSRIs for major depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| acupuncture (weak reaction acupoints) + SSRIs for major depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| acupuncture + placebo for major depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| acupuncture + SSRIs for major depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| acupuncture and moxibustion for major depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Aerobic exercise intervention for major depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Aia for major depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 3 |
|---|
| Aripiprazole for major depressive disorder | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 2 |
|---|
| Aripiprazole + IEM (Ingestible Event Marker) for major depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Aticaprant for major depressive disorder | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 5 |
|---|
| Auricular Acupuncture for major depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Azetukalner for major depressive disorder | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 4 |
|---|
| Behavioral Activation for major depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Behavioural Activation (BA) Therapy for depressive disorder, treatment-resistant | Trials ended early, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Behavioural Activation (BA) Therapy for major depressive disorder | Trials ended early, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Bilateral implantation of DBS system to Habeluna for depressive disorder, treatment-resistant | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| BPL-003 for depressive disorder, treatment-resistant | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 2 |
|---|
| Bupropion + Escitalopram + Venlafaxine + SERTRALINE for major depressive disorder | Trials ended early, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Cca for major depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Cholecalciferol for major depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| chronobiological augmentation for major depressive disorder | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| CI/BNST stimulation for major depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| CI/BNST stimulation + ITP Stimulation + No stimulation for major depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| CI/BNST stimulation + No stimulation for major depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Clozapine for major depressive disorder | Trials ended early, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Cognitive Behavioral Therapy (CBT) for major depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Cognitive Behavioral Therapy (CBT) + Whole-Body Hyperthermia for major depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Cognitive Behavioral Therapy (CBT) + Whole-Body Hyperthermia (WBH) for major depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Cognitive Behavioral Therapy + Psilocybin for major depressive disorder | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Cognitive task + Left DLPFC tDCS for major depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Cognitive task + Right DLPFC tDCS for major depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Counseling + Biospecimen Collection + Interview + Survey Administration + Psilocybin for depressive disorder | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Curcumin for major depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Curcumin and Fluoxetine for major depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Dbs for major depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| DBS + No Stimulation (Sham) for major depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Deep Brain Stimulation for depressive disorder, treatment-resistant | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Deep Brain Stimulation for major depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 2 |
|---|
| Deep Brain Stimulation (DBS) for depressive disorder, treatment-resistant | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Deep Brain Stimulation Model 3387 Model 3389 for depressive disorder, treatment-resistant | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Deep Brain Stimulation Model 3387 Model 3389 for major depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| deep brain stimulation with short & long pulse width for depressive disorder, treatment-resistant | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| deep brain stimulation with short & long pulse width for major depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Deep Brain Stimulation, implanted for depressive disorder, treatment-resistant | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Deep brain stimulation(Active) + Deep brain stimulation(Sham) for depressive disorder, treatment-resistant | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Deep brain stimulation(Active) + Deep brain stimulation(Sham) for major depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Deep Brain Stimulation(DBS) + Esketamine for depressive disorder, treatment-resistant | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Device: Directional Deep Brain Stimulation for depressive disorder, treatment-resistant | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Dextromethorphan and Bupropion Sustained-Release Tablets for major depressive disorder | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Diet-as-Usual (DAU) + LCHF Ketogenic Diet for major depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Dietary vitamin D for major depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Dimethyltryptamine for major depressive disorder | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 2 |
|---|
| Double Active: Active portable transcranial stimulation (ptES) and active internet-based behavioral therapy (iBT) for major depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| edupression.com® for depressive disorder, treatment-resistant | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| edupression.com® for major depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Electroacupuncture for depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Electroacupuncture for major depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Elunetirom for major depressive disorder | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Emono for depressive disorder, treatment-resistant | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Escitalopram + Esketamine + Venlafaxine + Duloxetine + SERTRALINE for depressive disorder, treatment-resistant | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 2 |
|---|
| Esketamine for depressive disorder, treatment-resistant | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 10 |
|---|
| Esketamine for major depressive disorder | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 7 |
|---|
| Esketamine + Esketamine Hydrochloride + Ketamine Hydrochloride for depressive disorder, treatment-resistant | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Esketamine + Esketamine Hydrochloride + Ketamine Hydrochloride for major depressive disorder | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 2 |
|---|
| Esketamine Treatment as Usual (ESK) + Virtual-Reality-based mindfulness intervention for depressive disorder, treatment-resistant | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Esketamine Treatment as Usual (ESK) + Virtual-Reality-based mindfulness intervention for major depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Estradiol for major depressive disorder | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Experimental regimen for depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Facilitate tDCS + CR for major depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Fluoxetine for depressive disorder | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Fluoxetine for major depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 5 |
|---|
| Fluoxetine + Imipramine for dysthymic disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Fluoxetine + Imipramine for major depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Hatha Yoga Practice Group for major depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Healthy Activity Program (HAP) for depressive disorder | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| High intensity whole-body infrared heating for major depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 2 |
|---|
| High Monetary Incentive (HMI) + Message-Based Psychotherapy (MBP) for depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| High Monetary Incentive (HMI) + Message-Based Psychotherapy with Monthly Video-Chat Psychotherapy for depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| High Monetary Incentive (HMI) + Message-Based Psychotherapy with Weekly Video-Chat Psychotherapy for depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| High Monetary Incentive (HMI) + Video-Chat Psychotherapy (VCP) for depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Individualized rTMS (transcranial magnetic stimulation) for depressive disorder | Trials ended early, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Integration Therapy for depressive disorder, treatment-resistant | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| ITP Stimulation for major depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Ketamine for depressive disorder, treatment-resistant | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 2 |
|---|
| Ketamine for major depressive disorder | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 2 |
|---|
| Ketamine Hydrochloride for depressive disorder, treatment-resistant | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Ketamine Hydrochloride for major depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Ketogenic Diet for depressive disorder, treatment-resistant | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 2 |
|---|
| Ketogenic Diet for major depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 2 |
|---|
| LCHF Ketogenic Diet for major depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Left DLPFC tDCS for major depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| light box + Wake Therapy + LITHIUM for major depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Lithium carbonate + perospirone hydrochloride for depressive disorder | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Low Monetary and Alternative Incentive (LMAI) + Message-Based Psychotherapy (MBP) for depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Low Monetary and Alternative Incentive (LMAI) + Message-Based Psychotherapy with Monthly Video-Chat Psychotherapy for depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Low Monetary and Alternative Incentive (LMAI) + Message-Based Psychotherapy with Weekly Video-Chat Psychotherapy for depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Low Monetary and Alternative Incentive (LMAI) + Video-Chat Psychotherapy (VCP) for depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Lurasidone for major depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Magnesium for major depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Medtronic Activa PC+S System for depressive disorder, treatment-resistant | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Medtronic Activa SC DBS, Lead Model 3387 for depressive disorder, treatment-resistant | Trials ended early, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Medtronic Percept PC DBS system for depressive disorder, treatment-resistant | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Medtronic Percept PC DBS system for major depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Medtronic SenSight Directional DBS lead for depressive disorder, treatment-resistant | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Medtronic Summit RC+S DBS system for depressive disorder, treatment-resistant | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Medtronic Summit RC+S DBS system for major depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Message-based psychotherapy (MBP) for depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Message-Based Psychotherapy (MBP) + Message-Based Psychotherapy with Monthly Video-Chat Psychotherapy for depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Message-Based Psychotherapy (MBP) + Message-Based Psychotherapy with Weekly Video-Chat Psychotherapy for depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Message-Based Psychotherapy with Monthly Video-Chat Psychotherapy + Video-Chat Psychotherapy (VCP) for depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Message-Based Psychotherapy with Weekly Video-Chat Psychotherapy + Video-Chat Psychotherapy (VCP) for depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Midazolam Placebo Solution + Esketamine for major depressive disorder | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Mindfulness-centered psilocybin-assisted therapy + Music-centered psilocybin-assisted therapy + Psilocybin for depressive disorder, treatment-resistant | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Nitrous Oxide for depressive disorder, treatment-resistant | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 4 |
|---|
| Nitrous Oxide for major depressive disorder | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 6 |
|---|
| Nmdae for major depressive disorder | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Oculus VR headset for depressive disorder, treatment-resistant | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Olanzapine and Fluoxetine combination (OFC) for depressive disorder, treatment-resistant | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| one night of sleep deprivation and two FDG PET scans for major depressive disorder | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Perospirone hydrochloride tablets for depressive disorder | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Placebo for depressive disorder, treatment-resistant | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Placebo + Escitalopram + Venlafaxine + Duloxetine + SERTRALINE for depressive disorder, treatment-resistant | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Placebo + Psilocybin for major depressive disorder | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Placebo + Psilocybin + Propofol for major depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Placebo of trazodone + Psilocybin for depressive disorder, treatment-resistant | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Psa for major depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Psilocybin for depressive disorder, treatment-resistant | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 8 |
|---|
| Psilocybin for major depressive disorder | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 19 |
|---|
| Psilocybin + Modafinil for major depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Psilocybin + PIMAVANSERIN for major depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Psilocybin + PIMAVANSERIN + Modafinil for major depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Psilocybin + Placebo for major depressive disorder | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Psilocybin + ZOLPIDEM for major depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Psilocybin + ZOLPIDEM + Modafinil for major depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Psilocybin + ZOLPIDEM + PIMAVANSERIN for major depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Psilocybin + ZOLPIDEM + PIMAVANSERIN + Modafinil for major depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Randomized, staggered withdrawal phase for depressive disorder, treatment-resistant | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Randomized, staggered withdrawal phase for major depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Receive tDCS+CR for major depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Relapse prevention cognitive behavioral therapy (CBT) for major depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Right DLPFC tDCS for major depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| rTMS treatment + Ketamine for major depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Sertraline for major depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| sertraline, lithium for major depressive disorder | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| sham acupuncture + SSRIs for major depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 2 |
|---|
| Sodium lactate for major depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| SPT-300 for major depressive disorder | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| SSRI/SNRI + Esketamine for depressive disorder, treatment-resistant | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| SSRI/SNRI + Esketamine for major depressive disorder | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Stanford Accelerated Intelligent Neuromodulation Therapy (SAINT®) with the Magnus Neuromodulation System for depressive disorder, treatment-resistant | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Stimulation-ON for major depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Structured Integrated Reframing Therapy (SIRT) for major depressive disorder | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Structured Integrated Reframing Therapy (SIRT) + Psilocybin for major depressive disorder | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Supportive psychotherapy + Psilocybin for major depressive disorder | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Supportive psychotherapy + Psilocybin + MICROCRYSTALLINE CELLULOSE for major depressive disorder | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| tDCS for depressive disorder, treatment-resistant | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 2 |
|---|
| tDCS for major depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 2 |
|---|
| tDCS (Eldith DC-Stimulator (CE certified)) for major depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 2 |
|---|
| tDCS over DLPFC for major depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Transcranial Direct Current Stimulation for major depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 6 |
|---|
| transcranial direct current stimulation (tDCS) for major depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Transcranial direct current stimulation (tDCS) on the Left DLPFC for major depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Transcranial direct current stimulation (tDCS) on the right VLPFC for major depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Transcranial Direct Current Stimulation + SERTRALINE for major depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Trazodone 5mg + Psilocybin for depressive disorder, treatment-resistant | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Tsa for major depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Video-chat Psychotherapy (VCP) for depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Vitamin d for seasonal affective disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Vitamin D 100 micrograms for depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Wbh for major depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Whole-Body Hyperthermia for depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Whole-Body Hyperthermia for major depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Whole-body hyperthermia + standard medical care for depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Xiaochaihu Granules (Low Dose) for depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|
| Yband(YDT-201N) for major depressive disorder | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
|---|